The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $3,505.20 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which has a firm fixed price, is for the supply of ABRYSVO VIAL WITH DILUENT SYRGS, medical supplies used in healthcare settings. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which covers the delivery of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $16,971.16 to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of "ABRYSVO VIAL WITH DILUENTS", a pharmaceutical product, with a performance period ending on July 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a firm fixed-price delivery order valued at $1,765.60 with an ultimate completion date of January 22, 2025. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, to support military healthcare programs. Amerisourcebergen also holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,280.44 firm-fixed-price delivery order is for the supply of "ABRYSVO VIAL WITH DILUENT SYRGS", with an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $1,612.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with a completion date of October 25, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,731.44 firm fixed-price delivery order is for the supply of 4565520786 ABRYSVO VIAL WITH DILUENT SYRGS, a medical supply product. The contract has an ultimate completion date of August 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of ABRYSVO vials with diluent syringes. The $26,181.72 firm fixed-price Delivery Order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has an ultimate completion date of November 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a leading global pharmaceutical distribution company, to provide ABRYSVO VIAL WITH DILUENTS. The contract has a ceiling value of $8,762.40 and a period of performance through March 13, 2024. This delivery order is issued under Amerisourcebergen's $999,999,999.00 indefinite delivery contract with DLA, which serves as the primary vehicle for the company to deliver pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,504.96 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of ABRYSVO VIAL WITH DILUENTS, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,403.84 firm fixed-price delivery order is for ABRYSVO VIAL WITH DILUENT SYRGS, a medical product, with a completion date of January 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...